Advertisement

Journal of Maxillofacial and Oral Surgery

, Volume 18, Issue 2, pp 197–202 | Cite as

Management of Odontogenic Fascial Space Infection in Hemophilia Patients: A Proposed Protocol

  • Md. Kalim AnsariEmail author
  • Ghulam sarwar Hashmi
  • Syed Saeed Ahmed
  • Sajjad Abdur Rahman
  • Tabishur Rahman
Clinical Paper
  • 58 Downloads

Abstract

Purpose

The purpose of this study was to suggest a protocol for the management of odontogenic space infections in patients with hemophilia which is often incompletely addressed by clinicians because of the fear of excessive bleeding leading to prolonged morbidity.

Methods and Results

Six diagnosed cases of hemophilia (four cases of hemophilia A and two cases of hemophilia B) with odontogenic fascial space infection were included in the study. Apart from routine investigations, assessments were also done to identify inhibitors to factor VIII/IX. Factor VIII/IX was replaced along with infusion of factor eight inhibitor bypass activity (FEIBA) one hour before incision and drainage. All the cases were treated by incision and drainage along with removal of foci under local anesthesia. The postoperative outcome was uneventful in all cases except one in which postoperative bleeding was noted from the extraction site on the third day which was again managed following the designed protocol.

Conclusion

Maintaining good oral hygiene and seeking early dental care are of prime importance in patients with hemophilia to avoid invasive procedures. However, if odontogenic infection develops in these patients, performing timely incision and drainage using our protocol will minimize the complications and give successful outcome.

Keywords

Hemophilia Factor VIII and IX Gelatin sponge Fascial space infection Third molar extraction 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declared that they have no conflict of interest.

Informed Consent

Informed consents were obtained from all the patients.

References

  1. 1.
    Patton LL (2003) Bleeding and clotting disorders. In: Burket’s oral medicine: diagnosis and treatment. 10th edn. BC Decker, Hamilton, pp 454–477Google Scholar
  2. 2.
    Rickard K (1995) Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1(Suppl.l):8–13CrossRefGoogle Scholar
  3. 3.
    Stubbs M, Lloyd J (2001) A protocol for the dental management of von Willebrand’s disease, haemophilia A and haemophilia B. Aust Dent J 46(1):37–40CrossRefGoogle Scholar
  4. 4.
    Lloyd J et al (2000) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders in Australia. Melbourne, Medical Advisory Panel for HFA (AHCDO)Google Scholar
  5. 5.
    Sudheesh KM et al (2016) ‘Antihemophilic factor is not the only answer for all factor VIII deficiencies’. Case report of odontogenic infection in a patient with hemophilia A, complicated by factor VIII inhibitors, and managed by transfusion of antihemophilic factor and factor VIII inhibitor bypass activity. Indian J Dent 7(3):149–152CrossRefGoogle Scholar
  6. 6.
    Franchini M (2014) Current management of hemophilia B: recommendations, complications and emerging issues. Expert Rev Hematol 7(5):573–581CrossRefGoogle Scholar
  7. 7.
    Bahl R, Sandhu S, Singh K, Sahai N, Gupta M (2014) Odontogenic infections: microbiology and management. Contemp Clin Dent 5(3):307–311CrossRefGoogle Scholar
  8. 8.
    Rafique S, Fiske J, Palmer G, Daly B (2013) Special care dentistry, 1: dental management of patients with inherited bleeding disorders. Dent Update 40(8):613–616CrossRefGoogle Scholar
  9. 9.
    Farrkh A, Garrison E, Closmann JJ (2016) Dental surgical management of the patient with hemophilia. Gen Dent 64(4):14–17Google Scholar
  10. 10.
    Nilsson IM (1994) Hemophilia. Pharmacia Plasma Products, StockholmGoogle Scholar
  11. 11.
    Shapiro SS, Huntin M (1975) Acquired inhibitors to the blood coagulation factors. Sem Thromb Hemost 1:336Google Scholar
  12. 12.
    Sultan Y (1992) The French Hemophilia Study Group. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost 67:600–602CrossRefGoogle Scholar
  13. 13.
    Kasper CK (1989) Treatment of factor VIII inhibitors. Prog Hemost Thromb 9:57–86Google Scholar
  14. 14.
    Lusher JM (1987) Factor VIII inhibitors. Etiology, characterization, natural history, and management. Ann N Y Acad Sci 509:89–102CrossRefGoogle Scholar
  15. 15.
    Nilsson IM, Hedner U, Björlin G (1973) Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide. Ann Intern Med 78:91–95CrossRefGoogle Scholar
  16. 16.
    Nilsson IM, Hedner U (1976) Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol 16:369–382CrossRefGoogle Scholar
  17. 17.
    Brewer A (2008) Dental management of patients with inhibitors to factor VIII or factor IX. World Federation of Haemophilia, Montréal (treatment of haemophilia monograph, no 45) Google Scholar

Copyright information

© The Association of Oral and Maxillofacial Surgeons of India 2018

Authors and Affiliations

  • Md. Kalim Ansari
    • 1
    Email author
  • Ghulam sarwar Hashmi
    • 1
  • Syed Saeed Ahmed
    • 1
  • Sajjad Abdur Rahman
    • 1
  • Tabishur Rahman
    • 1
  1. 1.Department of Oral and Maxillofacial SurgeryAligarh Muslim UniversityAligarhIndia

Personalised recommendations